ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2926

Rorc Positive Th17, Th17/Th1, and Th17.1 Cells from the Blood of Treatment NaïVe RA Patients Differ in IL-17A but Are All Pathogenic When Co-Cultured with RA Synovial Fibroblasts

Sandra M.J. Paulissen1, Jan Piet van Hamburg2, Nadine Davelaar2, Wendy Dankers3, Patrick Asmawidjaja2, Anne-Marie Otten-Mus2 and Erik Lubberts2, 1Room Nb-84, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, 2Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 3Rheumatology, Erasmus MC, University Medical Center, Rotterdam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cytokines, Fibroblasts, rheumatoid arthritis (RA) and transcription factor, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Poster Session II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: T cells play a central role in the early stages of rheumatoid arthritis (RA). In this context, we have shown increased proportions of memory CCR6+ Th cells in the blood of treatment naïve patients with early RA compared to healthy individuals. These cells express high levels of IL-17A and are TNFalpha positive. In addition, these memory CCR6+ Th cells induced a proinflammatory loop when co-cultured with RA synovial fibroblasts. This interaction may underlie the development of chronic synovitis. Since the memory CCR6+ T cell populations is a heterogeneous population consisting of e.g. Th17, Th17/Th1, and Th17.1 subpopulations we examined the presence and pathogenic potential of these subpopulations from the blood of treatment naïve patients with early RA.

Methods:   Memory CCR6+ Th cell subpopulations from the blood of treatment naive patients with early RA were distinguished based on chemokine receptor expression. Within these populations, cytokine and transcription factor expression were examined. In addition, CCR6+ subpopulations were sorted by FACS from peripheral blood of treatment naïve patients with early RA and analyzed for their pathologic potential in a co-culture system with RA derived synovial fibroblasts (RASF).

Results:   Based on the expression of CXCR3 and CCR4 four memory CCR6+ Th cell subpopulations were distinguished: Th17, Th17/Th1, Th17.1, and double negative (DN) cells. All four CCR6+ subpopulations expressed RORC, but differ in IL-17A, IL-17F, IL-22, IFNgamma, and T-bet expression. Furthermore, all four subpopulations showed increased pathological potential in co-culture with RASF compared to naive and the classical Th1 cells. Interestingly, even Th17.1, the subpopulation with the lowest IL-17A expression, displayed high pathological potential as shown by stimulating IL-1β, IL-6, IL-8, COX-2 and MMP-3 expression upon co-culture with RASF.

Conclusion:   The memory CCR6+ Th subpopulations differ in IL-17A, IFNgamma and T-bet expression However, all subpopulations express RORC. Interestingly, all subpopulations possess strong pathological potential in stimulating RASF to induce expression of proinflammatory cytokines and MMPs. These findings indicate that in addition to Th17 cells, also other CCR6+ Th subpopulations play a prominent role in the pathogenesis of synovial inflammation despite low IL-17A. Further insight in the molecular phenotype of these subpopulations is warranted to optimize targeted therapy in RA.


Disclosure: S. M. J. Paulissen, None; J. P. van Hamburg, None; N. Davelaar, None; W. Dankers, None; P. Asmawidjaja, None; A. M. Otten-Mus, None; E. Lubberts, None.

To cite this abstract in AMA style:

Paulissen SMJ, van Hamburg JP, Davelaar N, Dankers W, Asmawidjaja P, Otten-Mus AM, Lubberts E. Rorc Positive Th17, Th17/Th1, and Th17.1 Cells from the Blood of Treatment NaïVe RA Patients Differ in IL-17A but Are All Pathogenic When Co-Cultured with RA Synovial Fibroblasts [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/rorc-positive-th17-th17th1-and-th17-1-cells-from-the-blood-of-treatment-naive-ra-patients-differ-in-il-17a-but-are-all-pathogenic-when-co-cultured-with-ra-synovial-fibroblasts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rorc-positive-th17-th17th1-and-th17-1-cells-from-the-blood-of-treatment-naive-ra-patients-differ-in-il-17a-but-are-all-pathogenic-when-co-cultured-with-ra-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology